PMID: 3754610May 5, 1986Paper

Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat

Life Sciences
R HammerH Ladinsky

Abstract

The heterogeneity of muscarine receptors was examined in two brain regions (cerebral cortex and cerebellum) and in some parasympathetically innervated peripheral tissues (heart, salivary gland and intraorbital lacrimal gland), by in vitro binding techniques. As a tool, we used a new antimuscarinic compound, AF-DX 116 (see text for structural formula and chemical name). In competition experiments against 3H-N-methylscopolamine (3H-NMS) or 3H-pirenzepine (3H-PZ), AF-DX 116 was found to bind with high affinity to muscarine receptors in the heart and cerebellum (KD's approximately equal to 115 nM), with intermediate affinity to M1 receptors in neuronal tissue (KD = 760 nM) and with low affinity to receptors in exocrine glands (KD's approximately equal to 3200 nM). Its receptor interaction was found to be of the simple, competitive type. Thus, AF-DX 116 shows a novel cardioselective profile. On the basis of the results which demonstrate that the muscarine receptors in the heart and exocrine glands are clearly distinct, it is proposed that these receptors may be subclassified as M2 cardiac type and M2 glandular type muscarine receptors.

Citations

Jan 1, 1991·Archives of Insect Biochemistry and Physiology·E A AbdallahA T Eldefrawi
Jul 1, 1990·Medicinal Research Reviews·C Melchiorre
Oct 1, 1989·Naunyn-Schmiedeberg's Archives of Pharmacology·P WormsK Biziere
Apr 1, 1988·Pflügers Archiv : European journal of physiology·S Tsuji, K Kuba
Apr 1, 1989·Naunyn-Schmiedeberg's Archives of Pharmacology·K J van Charldorp, P A van Zwieten
Dec 1, 1990·Digestive Diseases and Sciences·A PfeifferM Herawi
Jan 1, 1993·Psychopharmacology·J P KanR Boigegrain
Dec 1, 1994·Archives of Pharmacal Research·S W LeeJ G Kim
Jul 1, 1994·European Journal of Drug Metabolism and Pharmacokinetics·E CeredaA Sagrada
Nov 6, 1989·Brain Research·J MurugaianH Sapru
Nov 10, 1987·European Journal of Pharmacology·F MartosR Hammer
Sep 13, 1988·European Journal of Pharmacology·L Noronha-BlobW J Kinnier
Oct 26, 1988·European Journal of Pharmacology·S B FreedmanE A Harley
Mar 15, 1988·European Journal of Pharmacology·E MonferiniH Ladinsky
Sep 23, 1988·European Journal of Pharmacology·X M ZhouH Yoshida
Dec 6, 1988·European Journal of Pharmacology·M Eltze, V Figala
Jul 14, 1988·European Journal of Pharmacology·J P DehayeJ Christophe
Jun 22, 1988·European Journal of Pharmacology·L Nilvebrant, B Sparf
May 20, 1988·European Journal of Pharmacology·K J Van CharldorpP A Van Zwieten

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.